Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Fischbach

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|March 10, 2023
Jörg M Fegert, Mario Bauer, Myriam Bea, et al.
European Journal of Pediatrics|January 12, 2013
Immunogenicity and safety of the quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) in 2-10-year-old children: results of an open, randomised, controlled studyMarkus Knuf, Olivier Romain, Klaus Kindler, et al.
Vaccine|March 23, 2011
An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix™ hexa is immunogenic, with an acceptable safety profile in 12-23-month-old childrenMarkus Knuf, Anna Pantazi-Chatzikonstantinou, Ulrich Pfletschinger, et al.
The Pediatric Infectious Disease Journal|December 22, 2016
Safety and Immunogenicity of the Quadrivalent Meningococcal Serogroups A, C, W and Y Tetanus Toxoid Conjugate Vaccine Coadministered With Routine Childhood Vaccines in European Infants: An Open, Randomized TrialJose Manuel Merino Arribas, Alfonso Carmona Martínez, Michael Horn, et al.
The Pediatric Infectious Disease Journal|April 6, 2018
Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib and PHiD-CV When Coadministered With MenACWY-TT in Infants: Results of an Open, Randomized TrialJose Manuel Merino Arribas, Alfonso Carmona Martínez, Michael Horn, et al.
BMJ Open Sport & Exercise Medicine|August 3, 2023
Global Alliance for the Promotion of Physical Activity: the Hamburg DeclarationJürgen M Steinacker, Willem van Mechelen, Wilhelm Bloch, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|March 10, 2023
Jörg M Fegert, Mario Bauer, Myriam Bea, et al.
European Journal of Pediatrics|January 12, 2013
Immunogenicity and safety of the quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) in 2-10-year-old children: results of an open, randomised, controlled studyMarkus Knuf, Olivier Romain, Klaus Kindler, et al.
Vaccine|March 23, 2011
An investigational tetravalent meningococcal serogroups A, C, W-135 and Y-tetanus toxoid conjugate vaccine co-administered with Infanrix™ hexa is immunogenic, with an acceptable safety profile in 12-23-month-old childrenMarkus Knuf, Anna Pantazi-Chatzikonstantinou, Ulrich Pfletschinger, et al.
The Pediatric Infectious Disease Journal|December 22, 2016
Safety and Immunogenicity of the Quadrivalent Meningococcal Serogroups A, C, W and Y Tetanus Toxoid Conjugate Vaccine Coadministered With Routine Childhood Vaccines in European Infants: An Open, Randomized TrialJose Manuel Merino Arribas, Alfonso Carmona Martínez, Michael Horn, et al.
The Pediatric Infectious Disease Journal|April 6, 2018
Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib and PHiD-CV When Coadministered With MenACWY-TT in Infants: Results of an Open, Randomized TrialJose Manuel Merino Arribas, Alfonso Carmona Martínez, Michael Horn, et al.
BMJ Open Sport & Exercise Medicine|August 3, 2023
Global Alliance for the Promotion of Physical Activity: the Hamburg DeclarationJürgen M Steinacker, Willem van Mechelen, Wilhelm Bloch, et al.
Pageof 3